Resource

Detecting genetic abnormalities in hematological and CNS malignancies with chromosomal microarray analysis

In this webinar, Dr. Lina Shao, current chair of the cytogenetics subcommittee of the American College of Medical Genetics and Genomics (ACMG), explains the advantages of cytogenomic studies using chromosomal microarray analysis (CMA) and their implications for oncology research.

This webinar will focus on:

Identifying acquired abnormalities in hematological malignancies and solid tumors
Providing insights into the WHO‑defined genetic abnormalities in B‑ALL and essential genetic abnormalities in oligodendroglioma
Understanding how CMA provides a comprehensive view of the whole genome, thus enabling accurate identification of intrachromosomal amplification of chromosome 21 (iAMP21) in B‑ALL and 1p/19q co‑deletion in oligodendrogliomas

Speakers

Lina Shao, MD, PhD
Clinical Professor, Pathology and Pediatrics,
The University of Michigan, Ann Arbor

Mary Napier
Senior Product Manager,
Thermo Fisher Scientific

Please fill out the short form below to view the recorded webinar.

(*Indicates a mandatory field)

First name *

Last name *

Company / institution *

Job Role *

Phone *

Email *

City *

Country / region *

Would you like to be contacted by an expert? *

Yes

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.